All Stories

  1. One-year outcome after endobronchial valve treatment of chronic obstructive pulmonary disease – a nationwide real-life cohort study
  2. Cytomegalovirus Infection and Lung Function in Liver Transplant Recipients: A Nationwide Cohort Study
  3. Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study
  4. Impaired Lung Function in Liver Transplant Recipients Compared With the General Population: A Nationwide Matched Cohort Study
  5. Haemodynamic responses to small muscle mass exercise before and after lung transplantation in end‐stage chronic obstructive pulmonary disease
  6. A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD)
  7. ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities
  8. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation 2026 Adult Lung Transplantation Report: A Contemporary Analysis of Trends and Outcomes by Recipient Sex
  9. Non-Aspergillus fumigatus mould infections in lung transplant recipients: an international, multicentre, case–control study
  10. Interferon-gamma release assay screening before solid organ transplantation in a low-incidence country: a prospective single-center cohort study
  11. Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation
  12. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2026 Annual Pediatric Heart Transplantation Report, Trends and Post-transplant Outcomes by Recipient Sex
  13. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2026 Adult Heart Transplantation: A contemporary analysis of trends and outcomes by recipient sex
  14. Respiratory muscle strength after lung volume reduction surgery
  15. Markers of inflammation and lung function in liver transplant recipients: results from a nationwide cohort study
  16. Thrombomodulin and syndecan-1 and association with lung function in liver transplant recipients
  17. Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement
  18. Frequency of Viral Monitoring to Detect Cytomegalovirus Infection and Prevent Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study
  19. Outcomes and management strategies of pregnancies after heart and lung transplantation across Europe
  20. Letter to the Editor Re: Commentary from the Melbourne Lung Transplant Group on the 2025 ISHLT Adult Lung Transplant DCD Report
  21. Booster Vaccination Against Invasive Pneumococcal Disease and Hepatitis B in Previously Vaccinated Solid Organ Transplant Recipients Without Seroprotection
  22. Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
  23. Cytomegalovirus and Crohn’s disease as competing causes of small bowel inflammation after double-lung transplantation
  24. First report of bilateral Bronchial Rheoplasty for treating chronic bronchitis performed in a single procedure
  25. A European multi-center, randomized controlled trial of Pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation
  26. Impact of COVID-19 after lung transplantation: A retrospective multicenter comparison of clinical outcomes in Denmark and Sweden
  27. Delay in lung volume reduction surgery due to the COVID-19 pandemic: impact on patient performance and mortality
  28. Lung volume reduction for the treatment of emphysema
  29. The Diagnostic Value of Soluble Epstein-Barr Virus BZLF1 Protein in Posttransplant Lymphoproliferative Disease Among Solid Organ and Hematopoietic Cell Transplant Recipients
  30. International experience of donation after circulatory death for lung transplantation. A special report from the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation
  31. Early renal failure after primary thoracic organ transplantation
  32. Pulmonary adaptations to 12 wk of supervised high intensity interval training in COPD: a nonrandomized controlled pilot study
  33. Risk Factors for Pneumothorax After Treatment With Endobronchial Valves: A Cohort Study
  34. Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation
  35. Impact of donor age ≥65 years on graft survival in large lung transplant cohorts
  36. On the measurement of glomerular filtration rate: An odyssey into the milieu intérieur
  37. Survival in Patients With Evidence of Pulmonary Thromboembolism on Ventilation‐Perfusion SPECT 12 Weeks After Double Lung Transplantation: A Retrospective Cohort Study
  38. Vintage vitality: Embracing older donor lungs for transplants
  39. Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection
  40. Adenovirus Infections and Disease in Solid Organ Transplant Recipients: Incidence and Outcomes
  41. Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres
  42. E-cigarette or vaping product use-associated lung injury (EVALI). A case report of a 19-year-old male in Denmark
  43. Lung transplantation in a patient with severe bronchiolitis obliterans secondary to Castleman disease
  44. Transmission of human herpesvirus-8 through liver transplantation and development of post-transplantation Kaposi sarcoma: A case report
  45. Feasibility and accuracy of DireCt Lung Ultrasound Evaluation technique to monitor extravascular lung water in porcine lungs
  46. Management of Post-transplant Infections in Collaborating Hospitals (MATCH) Programme: a prospective cohort of all transplant recipients at Copenhagen University Hospital—Rigshospitalet, Denmark
  47. Post-Transplantation Seroprotection Rates in Liver, Lung, and Heart Transplant Recipients Vaccinated Pre-Transplantation against Hepatitis B Virus and Invasive Pneumococcal Disease
  48. A case of native lung hyperinflation after single lung transplantation treated with lung volume reduction coils
  49. The Use of Bronchial Rheoplasty in Emphysema Patients Previously Treated with Endoscopic Lung Volume Reduction: A Case Series
  50. Porcine lungs perfused with three different flows using the 8-h open-atrium cellular ex vivo lung perfusion technique
  51. European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance
  52. Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves
  53. The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines
  54. Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies—a potential lifesaving intervention
  55. Assessing the role of phosphorylated S6 ribosomal protein in the pathological diagnosis of pulmonary antibody-mediated rejection
  56. Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel
  57. Long-term outcomes of lung transplantation with ex vivo lung perfusion technique
  58. Fraction of exhaled nitric oxide is higher in liver transplant recipients than in controls from the general population: a cohort study
  59. Predicting type 2 diabetes risk before and after solid organ transplantation using polygenic scores in a Danish cohort
  60. Predictors of reoperation after lung volume reduction surgery
  61. Differences in toll‐like receptor ligand‐induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical setting
  62. Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
  63. Graft survival in primary thoracic organ transplant recipients: A special report from the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation
  64. Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experience
  65. European Society of Organ Transplantation (ESOT) Consensus Statement on Prehabilitation for Solid Organ Transplantation Candidates
  66. Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function
  67. Severe Emphysema Treated with Bilateral Lung Sealant: A Case Series with Long-Term Follow-Up
  68. Performance of the 2009 CKDEPI, 2021 CKDEPI, and EKFC equations among high-risk patients in Denmark
  69. Associations between invasive aspergillosis and cytomegalovirus in lung transplant recipients: a nationwide cohort study
  70. ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly
  71. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study
  72. Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
  73. Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients—A Nationwide Cohort Study 2010–2019
  74. Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation
  75. Effect of influenza vaccination in solid organ transplant recipients: A nationwide population-based cohort study
  76. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-ninth adult lung transplantation report—2022; focus on lung transplant recipients with chronic obstructive pulmonary disease
  77. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth pediatric lung transplantation report — 2022; focus on pulmonary vascular diseases
  78. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report—2022; focus on transplant for restrictive heart disease
  79. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report—2022; focus on infant heart transplantation
  80. Post-Transplantation Anemia and Risk of Death Following Lung Transplantation
  81. Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
  82. Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death
  83. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
  84. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions
  85. The utility of transbronchial lung biopsies to guide the treatment decision in patients with rheumatic inflammatory diseases: a retrospective cross-sectional study
  86. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
  87. Estimating Renal Function Following Lung Transplantation
  88. Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up
  89. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
  90. National multi‐centre study found a low prevalence of severely impaired lung function in children and adolescents
  91. Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
  92. Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death
  93. Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study
  94. The evolution of the ISHLT transplant registry. Preparing for the future
  95. First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood
  96. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements
  97. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient characteristics
  98. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient characteristics
  99. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report — 2021; focus on recipient characteristics
  100. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric lung transplantation report — 2021; Focus on recipient characteristics
  101. Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study
  102. Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing
  103. Protein Signatures of Remodeled Airways in Transplanted Lungs with Bronchiolitis Obliterans Syndrome Obtained Using Laser-Capture Microdissection
  104. An Observational Prospective Cohort Study of Incidence and Outcome of Streptococcus pneumoniae and Hemophilus influenzae Infections in Adult Solid Organ Transplant Recipients
  105. Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients
  106. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study
  107. Lung transplantation for sarcoidosis: outcome and prognostic factors
  108. Incidence and Impact of Parvovirus B19 Infection in Seronegative Solid Organ Transplant Recipients
  109. Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves
  110. Prognostic impact of ventilation‐perfusion defects and pulmonary diffusing capacity after single lung transplantation
  111. International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation
  112. Comparison of 81mKrypton and 99mTc-Technegas for ventilation single-photon emission computed tomography in severe chronic obstructive pulmonary disease
  113. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review
  114. Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation
  115. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation
  116. Evidence of unilateral diaphragmatic paralysis on lung scintigraphy after double lung transplantation: impact on lung function and survival
  117. Felodipine and renal function in lung transplantation: A randomized placebo-controlled trial
  118. Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation
  119. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017
  120. Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative
  121. Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey
  122. Evaluation of an electronic, patient‐focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation
  123. Survival in patients with scintigraphic evidence of pulmonary thromboembolism 12 weeks after double lung transplantation
  124. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients
  125. Variation in Time to Peak Values for Different Lung Function Parameters After Double Lung Transplantation
  126. “Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”
  127. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial
  128. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation
  129. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
  130. Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
  131. Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome
  132. Lobar Quantification by Ventilation/Perfusion SPECT/CT in Patients with Severe Emphysema Undergoing Lung Volume Reduction with Endobronchial Valves
  133. Chronic pain after bilateral thoracotomy in lung transplant patients
  134. Urgent lung allocation system in the Scandiatransplant countries
  135. Lung Ultrasound in the Assessment of Pulmonary Complications After Lung Transplantation
  136. Lung transplantation after ex vivo lung perfusion in two Scandinavian centres
  137. Laser-capture microdissection, mass spectrometry and immunohistochemistry reveal pathologic alterations in the extracellular matrix of transplanted lungs
  138. The “Coil Associated Opacity” in endoscopic emphysema treatment. Friend or foe?
  139. Classification of death causes after transplantation (CLASS)
  140. Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
  141. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients
  142. Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
  143. A Nordic Multicenter Study on Size Mismatch in Bilateral Lung Transplantation
  144. Bronchoalveolar Lavage Practices in Lung Transplantation: Results of a Large-scale International Survey
  145. Phosphorylated P70 S6 Kinase and S6 Ribosomal Protein Value as Diagnostic Marker of Antibody-mediated Rejection in Lung Allografts: A Multicenter Study
  146. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia
  147. Donor Smoking and Older Age Increases Morbidity and Mortality After Lung Transplantation
  148. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading—A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation
  149. Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
  150. Lung ultrasound for the diagnosis of post-operative complications after lung transplantation
  151. Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?
  152. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study
  153. Is Histopathological Assessment Going to Remain the Gold Standard for Diagnosis of Pulmonary Allograft Rejection?
  154. Dichotomy in pulmonary graft- versus -host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation: TABLE 1
  155. The impact of underlying disease on baseline pulmonary function values after lung transplantation
  156. Diffusion capacity as a predictor of prognosis after onset of CLAD
  157. Lung Transplantation after Ex-Vivo Lung Perfusion in Two Scandinavian Centres
  158. Low Correlation in Longevity between Lung Grafts from the Same Donor
  159. FVC, TLC and CT as Independent Predictors for Prognosis after Onset of CLAD
  160. Long-term survival in lung transplant recipients depending on icu length of stay: outcome in a series of 653 consecutive patients
  161. Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival
  162. Impact of Age and Smoking History on the Selection of Donors for Lung Transplantation
  163. Prognosis of patients with alpha1-antitrypsine deficiency on long-term oxygen therapy
  164. Early laparotomy after lung transplantation: Increased incidence for patients with α1-anti-trypsin deficiency
  165. Endoscopic treatment of native lung hyperinflation using endobronchial valves in single-lung transplant patients: a multinational experience
  166. Catch-Up Growth Occurs after Diarrhea in Early Childhood
  167. Age-Related Decline in Lung Function in Patients Without CLAD After Double Lung Transplantation
  168. A Zero 90-Day Mortality After Lung Transplantation - What Is the Price?
  169. Restrictive Allograft Syndrome (RAS) in Lung Transplant Recipients Carries Uncertain Additional Prognostic Significance as Compared To BOS
  170. HIV testing of patients diagnosed with tuberculosis increased in Denmark during the period from 2007 to 2009
  171. Long Term Outcome after Bronchial Artery Revascularization in Double Lung Transplantation – A More Than Fifteen Year Follow-Up Study
  172. Lung Transplant Recipients Suspected of Antibody Mediated Rejection Treated with Plasmapheresis Have a Poor Prognosis
  173. Wasting Is Associated with Stunting in Early Childhood
  174. 726 Endoscopic Treatment of Native Lung Hyperinflation with One-Way Valves in Single Lung Transplant Patients: A Multinational Experience
  175. 526 Chronic Allograft Dysfunction after Lung Transplantation. A Comparison of RAS vs. BOS
  176. Treatment of Intractable Interstitial Lung Injury with Alemtuzumab after Lung Transplantation
  177. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diptheria–tetanus–pertussis vaccinations
  178. Outbreak of Salmonella Braenderup infections associated with Roma tomatoes, northeastern United States, 2004: a useful method for subtyping exposures in field investigations
  179. Community cohort study of rotavirus and other enteropathogens: Are routine vaccinations associated with sex-differential incidence rates?
  180. Intussusception in Early Childhood: A Cohort Study of 1.7 Million Children
  181. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection
  182. Cohort Study of Guinean Children: Incidence, Pathogenicity, Conferred Protection, and Attributable Risk for Enteropathogens during the First 2 Years of Life
  183. EnterotoxigenicEscherichia coliInfections and Diarrhea in a Cohort of Young Children in Guinea‐Bissau
  184. Protective Immunity after Natural Rotavirus Infection: A Community Cohort Study of Newborn Children in Guinea‐Bissau, West Africa
  185. Seven years' experience withCryptosporidium parvumin Guinea-Bissau, West Africa
  186. Community-based controlled trial of dietary management of children with persistent diarrhea: sustained beneficial effect on ponderal and linear growth